Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Associated Infections (U01)
The summary for the Partnerships to Improve Diagnosis and Treatment of Selected Drug-Resistant Healthcare-Associated Infections (U01) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
Federal Grant Title:
PARTNERSHIPS TO IMPROVE DIAGNOSIS AND TREATMENT OF SELECTED DRUG-RESISTANT HEALTHCARE-ASSOCIATED INFECTIONS (U01)
State governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) Independent school districts Public and State controlled institutions of higher education Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Applicants may submit more than one application, provided they are scientifically distinct. See Section IV.1 for application materials.
-To support the development of rapid diagnostics capable of identifying specific bacterial strains and drug resistant phenotypes for the following healthcare-associated pathogens: Clostridium difficile, Pseudomonas, Acinetobacter, Enterobacter, Klebsiella, Serratia, Proteus, and Stenotrophomonas (Pseudomonas) maltophilia. -To support the development of therapeutics for the same pathogens: Clostridium difficile, Pseudomonas, Acinetobacter, Enterobacter, Klebsiella, Serratia, Proteus, and Stenotrophomonas (Pseudomonas) maltophilia -FY2007 total anticipated amount to be awarded: $3 million